Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China · Delayed Price · Currency is CNY 6.73
-0.16 (-2.32%)
Jul 30, 2026, 11:29 AM CST
SHA:600222 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,785 | 1,758 | 1,941 | 2,070 | 1,961 | 1,605 |
Revenue Growth | 1.08% | -9.46% | -6.21% | 5.57% | 22.20% | 13.23% |
Gross Profit Gross Profit Growth | 493.47 | 488.33 | 500.1 | 561.55 | 468.4 | 456.85 |
Operating Income Operating Income Growth | 134.92 | 134.78 | 75.9 | 75.94 | -7.87 | 125.34 |
Net Income Net Income Growth | 61.07 | 60 | 50.53 | 43.56 | -72.2 | 6 |
Earnings Per Share EPS Growth | 0.11 | 0.11 | 0.09 | 0.08 | -0.13 | 0.01 |
EPS Growth | 97.91% | 19.49% | 17.31% | - | - | -80.00% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Drug R&D Services Drug R&D Services Growth | 241.51 |
Others Others Growth | 4.11 |
Offset of Business Segment Offset of Business Segment Growth | -57.49 |
Circulation of medicines and medicinal materials Circulation of medicines and medicinal materials Growth | 277.81 |
Pharmaceutical manufacturing Pharmaceutical manufacturing Growth | 1,292 |
Total Total Growth | 1,758 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 181.53 | 323.61 | 260.05 | 349.97 | 386.34 | 666.22 |
Total Debt Total Debt Growth | 974.84 | 770.59 | 1,025 | 780.03 | 665.92 | 1,225 |
Net Cash (Debt) Net Cash Growth | -793.31 | -446.98 | -764.79 | -430.07 | -279.58 | -558.53 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.43 | -0.81 | -1.37 | -0.76 | -0.50 | -1.00 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -161.45 | 47.16 | -39.59 | 43.74 | -124.41 | 99.66 |
Capital Expenditures CapEx Growth | -19.84 | -21.12 | -37.23 | -43.13 | -66.62 | -39.07 |
Free Cash Flow Free Cash Flow Growth | -181.28 | 26.04 | -76.82 | 0.6 | -191.03 | 60.58 |
Free Cash Flow Growth | - | - | - | - | - | 7717.75% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.65% | 27.78% | 25.76% | 27.13% | 23.89% | 28.47% |
Operating Margin | 7.56% | 7.67% | 3.91% | 3.67% | -0.40% | 7.81% |
Pretax Margin | 4.33% | 4.41% | 1.81% | 2.08% | -4.23% | 0.46% |
Profit Margin | 3.42% | 3.41% | 2.60% | 2.10% | -3.68% | 0.37% |
FCF Margin | -10.16% | 1.48% | -3.96% | 0.03% | -9.74% | 3.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.014 | 0.014 | 0.028 | 0.018 | - | 0.010 |
Dividend Per Share Growth | -50.00% | -50.00% | 55.56% | - | - | -37.50% |
Dividend Yield | 0.20% | 0.21% | 0.55% | 0.30% | - | 0.11% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 62.58 | 60.64 | 55.88 | 78.72 | - | 843.33 |
Forward PE | - | 47.05 | 47.05 | 47.05 | 47.05 | 47.05 |
P/FCF Ratio | - | 139.74 | - | 5673.80 | - | 83.46 |
PS Ratio | 2.13 | 2.07 | 1.45 | 1.66 | 1.81 | 3.15 |